(NP (NP-COOD (NP BCL-6/NN) and/CC (NP (NP the/DT molecular/JJ pathogenesis/NN) (PP of/IN (NP B-cell/NN lymphoma/NN)))) ./.)
(S (NP-SBJ (NP The/DT results/NNS) (VP presented/VBN (NP */-NONE-))) (VP identify/VBP (NP (NP the/DT first/JJ genetic/JJ lesion/NN) (VP associated/VBN (NP */-NONE-) (PP with/IN (NP (NP DLCL/NN) ,/, (NP (NP the/DT (ADJP most/RBS clinically/RB relevant/JJ) form/NN) (PP of/IN (NP NHL/NN)))))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ (NP no/DT proof/NN) (PP *ICH*-65/-NONE-)) (ADVP-TMP yet/RB) (VP exists/VBZ (PP-65 of/IN (NP (NP a/DT role/NN) (PP for/IN (NP these/DT lesions/NNS)) (PP in/IN (NP DLCL/NN pathogenesis/NN))))))) ,/, (NP-SBJ-COOD (NP (NP the/DT feature/NN) (PP of/IN (NP the/DT BCL-6/NN gene/NN product/NN))) ,/, (NP (NP its/PRP$ specific/JJ pattern/NN) (PP of/IN (NP expression/NN)) (PP in/IN (NP B/NN cells/NNS))) ,/, and/CC (NP (NP the/DT clustering/NN) (PP of/IN (NP lesions/NNS)) (VP disrupting/VBG (NP its/PRP$ regulatory/JJ domain/NN)))) (ADVP strongly/RB) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ (NP deregulation/NN) (PP of/IN (NP BCL-6/NN expression/NN))) (VP may/MD (VP contribute/VB (PP to/TO (NP DLCL/NN development/NN))))))) ./.)
(S (NP-SBJ (NP A/DT (ADJP more/RBR precise/JJ) definition/NN) (PP of/IN (NP (NP the/DT role/NN) (PP of/IN (NP BCL-6/NN)) (PP in/IN (NP (ADJP-COOD (ADJP normal/JJ) and/CC (ADJP neoplastic/JJ)) B-cell/NN development/NN))))) (VP is/VBZ (NP-PRD (NP the/DT goal/NN) (PP of/IN (NP (NP ongoing/JJ study/NN) (PP of/IN (NP (NP transgenic/JJ mice/NNS) (VP engineered/VBN (NP-103 */-NONE-) (S (NP-SBJ *-103/-NONE-) (VP-COOD either/CC (VP to/TO (VP express/VB (NP BCL-6/NN) (PP under/IN (NP heterologous/JJ promoters/NNS)))) or/CC (VP lacking/VBG (NP BCL-6/NN function/NN) (PP due/JJ to/TO (NP targeted/VBN deletions/NNS)))))))))))) ./.)
(S (PP In/IN addition/NN to/TO (S (NP-SBJ *-28/-NONE-) (VP contributing/VBG (PP to/TO (NP (NP the/DT understanding/NN) (PP of/IN (NP DLCL/NN pathogenesis/NN))))))) ,/, (NP-SBJ-28 (NP the/DT identification/NN) (PP of/IN (NP BCL-6/NN lesions/NNS))) (VP may/MD (VP have/VB (NP relevant/JJ clinical/JJ implications/NNS))) ./.)
(S (NP-SBJ DLCL/NN) (VP represent/VBP (NP (NP a/DT heterogeneous/JJ group/NN) (PP of/IN (NP (NP neoplasms/NNS) (SBAR (WHNP-29 which/WDT) (S (NP-SBJ-30 *T*-29/-NONE-) (VP are/VBP (VP treated/VBN (NP *-30/-NONE-) (ADVP homogeneously/RB) (PP despite/IN (NP the/DT fact/NN (SBAR that/IN (S (NP-SBJ (NP (QP only/RB 50/CD) %/NN) (PP of/IN (NP patients/NNS))) (VP experience/VBP (NP long-term/JJ disease-free/JJ survival/NN))))))))))))) (PRN -LRB-/-LRB- (NP (NP (NP Schneider/NNP) (ADVP et/FW al./FW)) (NP-TMP 1990/CD)) -RRB-/-RRB-)) ./.)
(S (NP-SBJ The/DT fact/NN (SBAR that/IN (S (NP-SBJ BCL-6/NN rearrangements/NNS) (VP identify/VBP (NP (NP (ADJP (ADVP-COOD (ADVP biologically/RB) and/CC (ADVP clinically/RB)) distinct/JJ) subsets/NNS) (PP of/IN (NP DLCL/NN))))))) (VP suggests/VBZ (SBAR that/IN (S (NP-SBJ these/DT lesions/NNS) (VP may/MD (VP be/VB (ADJP-PRD useful/JJ) (PP as/IN (NP markers/NNS)) (PP in/IN (NP (NP selection/NN) (PP of/IN (NP differential/JJ therapeutic/JJ strategies/NNS)) (PP based/VBN (PP on/IN (NP different/JJ risk/NN groups/NNS)))))))))) ./.)
(S (ADVP Furthermore/RB) ,/, (NP-SBJ-31 the/DT BCL-6/NN rearrangements/NNS) (VP can/MD (VP be/VB (VP used/VBN (NP-32 *-31/-NONE-) (S (NP-SBJ *-32/-NONE-) (VP to/TO (VP (VP-COOD (VP identify/VB (NP *RNR*-33/-NONE-)) and/CC (VP monitor/VB (NP *RNR*-33/-NONE-))) (NP-33 the/DT malignant/JJ clone/NN) (PP with/IN (NP sensitive/JJ PCR-based/JJ techniques/NNS)))))))) ./.)
(S (SBAR Since/IN (S (NP-SBJ-35 clinical/JJ remission/NN) (VP has/VBZ (VP been/VBN (VP observed/VBN (NP *-35/-NONE-) (PP in/IN (NP (NP a/DT significant/JJ fraction/NN) (PP of/IN (NP DLCL/NN cases/NNS))))))))) ,/, (NP-SBJ these/DT markers/NNS) (VP may/MD (VP serve/VB (PP as/IN (NP (NP critical/JJ tools/NNS) (PP for/IN (NP-COOD (NP (NP sensitive/JJ monitoring/NN) (PP of/IN (NP minimal/JJ residual/JJ disease/NN))) and/CC (NP (NP early/JJ diagnosis/NN) (PP of/IN (NP relapse/NN))))))) (PRN -LRB-/-LRB- (NP (NP (NP Gribben/NNP) (ADVP et/FW al./FW)) (NP-TMP 1993/CD)) -RRB-/-RRB-))) ./.)
